High levels of DEPDC1B predict shorter biochemical recurrence‑free survival of patients with prostate cancer
Shoumin Bai(Sun Yat-sen University), Hai Huang(Sun Yat-sen University)
Cited by 30
Related Papers
HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma
|Journal for ImmunoTherapy of Cancer|2020|95
Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
|Cancer Biology and Medicine|2021|52
Matrine suppresses invasion of castration-resistant prostate cancer cells by downregulating MMP-2/9 via NF-κB signaling pathway
|International Journal of Oncology|2016|45
B7 score and T cell infiltration stratify immune status in prostate cancer
|Journal for ImmunoTherapy of Cancer|2021|38